Table V.
Patient | Age, months | Stage | Risk group | 1st pathology | Primary site | Relapse time, months | Relapse or metastasis site |
---|---|---|---|---|---|---|---|
1 | 24 | III | HR | GNBn | Retroperitoneum | 28 | Intracranial |
2 | 84 | III | HR | NB UD | Retroperitoneum | 22 | Abdominal |
3 | 48 | III | HR | NB UD | Retroperitoneum | 8 | Abdominal |
4 | 48 | IV | HR | BM | Retroperitoneum, BM, bone | 22 | Intracranial |
5 | 17 | IV | MR | BM | Retroperitoneum, BM, bone | 12 | Abdominal |
6 | 46 | IV | HR | BM | Retroperitoneum and postmediastinum, BM | 22 | Intracranial |
7 | 25 | IV | HR | BM | Retroperitoneum, BM, orbit | 20 | Intracranial |
8 | 38 | IV | HR | BM | Retroperitoneum, BM | 4 | Lung |
HR, high risk; MR, medium risk; GNBn, nodular ganglioneuroblastoma; NB UD, undifferentiated neuroblastoma; BM, bone marrow.